SCHEMBL27770063

SCHEMBL27770063

CC(C)(C)OC(=O)NC(C(=O)OC1CCCCCCC1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 2/20 0.53
▸ MMP9 P14780 2/20 0.53
▸ ANPEP P15144 2/20 0.53
▸ LTA4H P09960 1/20 0.53
▸ LAP3 P28838 1/20 0.53
▸ NPEPPS P55786 1/20 0.53
▸ ERAP2 Q6P179 1/20 0.53
▸ ERAP1 Q9NZ08 1/20 0.53
▸ CTSS P25774 1/20 0.52
▸ CTSK P43235 1/20 0.52
▸ CACNA1B Q00975 5/20 0.50
▸ S1PR3 Q99500 1/20 0.44
▸ CYP2D6 P10635 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ CHRM2 P08172 2/20 0.42
▸ CHRM4 P08173 2/20 0.42
▸ CHRM5 P08912 2/20 0.42
▸ THRB P10828 2/20 0.42
▸ CHRM1 P11229 2/20 0.42
▸ CHRM3 P20309 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6347304 1.00 MMP2 (0.53) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL192802 0.88 CACNA1B (0.49) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL192801 0.88 CACNA1B (0.49) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL16789062 0.87 CTSS (0.49) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL193279 0.86 CACNA1B (0.52) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL193280 0.86 CACNA1B (0.52) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL16789066 0.86 CYP2D6 (0.64) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL16789065 0.84 CTSK (0.51) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL8512028 0.84 LMNA (0.60) CTSSCTSKCYP2D6LMNACHRM2
SCHEMBL16802186 0.84 CTSK (0.48) MMP2MMP9ANPEPLTA4HLAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101878208-B Substituted-quinoxaline-type-piperidine compounds and the uses thereof PURDUE PHARMA L.P. (US) 2014-10-15 — — CN disclosed
CN-101878208-A Quinoxaline-type-piperidine compounds that replaces and uses thereof PURDUE PHARMA LP 2010-11-03 — — CN disclosed
CN-101595100-A Piperidines as the heterocyclic substituted of ORL-1 part PURDUE PHARMA LP (US) 2009-12-02 — — CN disclosed
Send feedback